» Articles » PMID: 32943843

Application of Intravenous Lidocaine in Obese Patients Undergoing Painless Colonoscopy: A Prospective, Randomized, Double-Blind, Controlled Study

Overview
Specialty Pharmacology
Date 2020 Sep 18
PMID 32943843
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Propofol for procedural sedation and analgesia (PSA) for colonoscopy can result in a high prevalence of severe respiratory depression. Studies have shown that intravenous (IV) infusion of lidocaine can reduce propofol requirements significantly and increase the ventilatory response to carbon dioxide in humans. We tested the hypothesis that IV lidocaine could improve propofol-induced respiratory depression in obese patients during colonoscopy.

Methods: Ninety obese patients scheduled for painless colonoscopy were randomized to receive lidocaine (1.5 mg/kg, then 2 mg/kg/h, IV) or the same volume of 0.9% saline. Intraoperative sedation was provided by propofol. The primary outcome was the number of oxygen-desaturation episodes. Secondary outcomes were: the number of apnea episodes; total propofol consumption; time to the first hypoxia episode; time to consciousness loss; intraoperative hemodynamic parameters; awakening time; adverse events; duration of post-anesthesia care unit (PACU) stay; satisfaction of endoscopists and patients.

Results: Demographic characteristics between the two groups were comparable. The number of oxygen-desaturation episodes in group L (1.49±1.12) decreased by 0.622 (=0.018) compared with that in group N (2.11±1.32), and the number of apnea episodes in group L decreased by 0.533 (<0.001). Kaplan-Meier curves showed that the median time to the first hypoxia episode was longer in group L (86.78 s) than that in group N (63.83 s) (Log rank =0.0008). The total propofol consumption, awakening time, and duration of PACU stay were reduced in group L. There was no significant difference in the prevalence of adverse events (>0.05 for all). Satisfaction scores for endoscopists and patients in group L were higher than that in group N (<0.001).

Conclusion: Intravenous infusion of lidocaine could significantly reduce the number of oxygen-desaturation and apnea episodes in obese patients during painless colonoscopy. This method is worthy of clinical promotion.

Clinical Trials Registration: ChiCTR2000028937.

Citing Articles

Intravenous lidocaine decreased oxygen-desaturation episodes induced by propofol-based sedation for gastrointestinal endoscopy procedures: a prospective, randomized, controlled trial.

Qi X, Qi Y, Zhang K, Hao W, An L BMC Anesthesiol. 2025; 25(1):27.

PMID: 39799289 PMC: 11724489. DOI: 10.1186/s12871-025-02890-w.


Effect of Lidocaine on Ciprofol Dosage and Efficacy in Patients Who Underwent Gastroscopy Sedation.

Han Y, Zhang B, Jin L, Yu Z, He H Med Sci Monit Basic Res. 2024; 30:e945751.

PMID: 39506303 PMC: 11555886. DOI: 10.12659/MSMBR.945751.


Comparison of Fentanyl, Ketamine, and Lidocaine Combined with Propofol Anesthesia in Patients with Crohn Disease Undergoing Colonoscopy.

Chudzinski K, Szuldrzynski K, Jankowski M, Adamczyk K, Sokol-Kobielska E Med Sci Monit. 2024; 30:e944116.

PMID: 38822518 PMC: 11151790. DOI: 10.12659/MSM.944116.


Effect of intravenous lidocaine on outcomes in patients receiving propofol for gastrointestinal endoscopic procedures: an updated systematic review and meta-analysis.

Wu F, Zhan L, Xu W, Bian J Eur J Clin Pharmacol. 2023; 80(1):39-52.

PMID: 37962581 DOI: 10.1007/s00228-023-03589-y.


Comparison of propofol-esketamine versus propofol for anesthesia in gastroscopy: a double-blind, randomized controlled clinical trial.

Liu X, Xiao Q, Zhuang S Front Med (Lausanne). 2023; 10:1184709.

PMID: 37614948 PMC: 10442552. DOI: 10.3389/fmed.2023.1184709.


References
1.
De Oliveira Jr G, Duncan K, FitzGerald P, Nader A, Gould R, McCarthy R . Systemic lidocaine to improve quality of recovery after laparoscopic bariatric surgery: a randomized double-blinded placebo-controlled trial. Obes Surg. 2013; 24(2):212-8. DOI: 10.1007/s11695-013-1077-x. View

2.
Liao Y, Chuang M, Huang C, Tsai Y . Upper airway and its surrounding structures in obese and nonobese patients with sleep-disordered breathing. Laryngoscope. 2004; 114(6):1052-9. DOI: 10.1097/00005537-200406000-00018. View

3.
Carabalona J, Delwarde B, Duclos A, Le Goff M, Moulsma M, Citterio-Quentin A . Serum Concentrations of Lidocaine During Bariatric Surgery. Anesth Analg. 2018; 130(1):e5-e8. DOI: 10.1213/ANE.0000000000003905. View

4.
Ruehland W, Rochford P, ODonoghue F, Pierce R, Singh P, Thornton A . The new AASM criteria for scoring hypopneas: impact on the apnea hypopnea index. Sleep. 2009; 32(2):150-7. PMC: 2635578. DOI: 10.1093/sleep/32.2.150. View

5.
Plass F, Nicolle C, Zamparini M, Al Issa G, Fiant A, Le Roux Y . Effect of intra-operative intravenous lidocaine on opioid consumption after bariatric surgery: a prospective, randomised, blinded, placebo-controlled study. Anaesthesia. 2020; 76(2):189-198. DOI: 10.1111/anae.15150. View